MedPath

A study to investigate the pharmacokinetic profile of 3 doses of sublingual testosterone solution and their effect on physiological and subjective arousal in healthy, sexually functional premenopausal women.

Recruiting
Conditions
Pharmacokinetics of sublingual testosterone, female sexual arousal, Vaginal Pulse Amplitude (VPA)Farmacokinetiek sublinguale testosteron, seksuele opwinding bij vrouwen, vaginale pulse amplitude (VPA)
Registration Number
NL-OMON21403
Lead Sponsor
Emotional Brain BV
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
16
Inclusion Criteria

1. Provision of written informed consent;

2. Female 21-40 years of age;

Exclusion Criteria

1. Sexual dysfunction as determined by Sexual Function Questionnaire (SFQ) diagnostic scores (within ‘high probability of dysfunction’ or ‘possibility of dysfunction’ ranges) for all functional domains (desire, arousal-lubrication, arousal-sensation, orgasm and pain) as described by Quirk et al. 2005;

2. Subjects who had used testosterone therapy within 6 months before study entry;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath